| pitavastatin / Generic mfg. |
| Completed | 4 | 108 | | pitavastatin calcium tablet (test product) ;pitavastatin calcium tablet (reference product) ;pitavastatin calcium tablet (reference product) | Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine; Level of the institution：, Di Sand Pharmaceutical Group Co. Ltd. | Hyperlipidemia | | | | |
ChiCTR-TRC-11001742: Effects of SLCO1B1 Polymorphism and Pitavastatin on the Pharmacokinetics of Repaglinide in Chinese Healthy Volunteers |
|
|
| Completed | 4 | 12 | | 4 mg pitavastatin calcium+4mg repaglinide ;Placebo+4mg repaglinide | Third Xiangya Hospital, Central South University; Third Xiangya Hospital, Central South University, No sponsor | No | | | | |
ChiCTR-IPR-15005761: The effects and mechanism of statins on Glucose metabolism in elderly patients with atherosclerotic cardiovascular disease |
|
|
| Recruiting | 4 | 300 | | Atorvastatin calcium ;Atorvastatin calcium ;Rosuvastatin calcium ;Rosuvastatin calcium ;Pitavastatin calcium ;Pitavastatin calcium | Second Department of Cadre Ward, General Hospital of Jinan Military Region; General Hospital of Jinan Military Region, PLA GeneralLogistics Department of the Ministry of health care of special research projects(14BJZ27) | atherosclerotic cardiovascular disease | | | | |
| Completed | 4 | 70 | RoW | Pitavastatin, Livalo tab | Seoul National University Bundang Hospital, JW Pharmaceutical | Osteoporosis, Osteopenia, Hypercholesterolemia, Menopausal Osteoporosis | 02/22 | 12/23 | | |
ChiCTR1800017776: Effect of Pitavastatin on lipid-lowering, and Lipid-rich Carotid Plaques and in patients with dyslipidemia Using carotid ultrasound: A Prospective, Multicenter Study |
|
|
| Recruiting | 4 | 375 | | Pivastatin 2mg ;Pivastatin 4mg ;Pivastatin4mg and Ezetimibe10mg | Beijing CHAO-YANG Hospital, Xuanwu Hospital Capital Medical University; Level of the institution：, CR Double-Crane Pharmaceuticals Co., Ltd | Mixed dyslipidemia Primary hypercholesterolemia | | | | |
2022-000082-41: A clinical trial is being conducted to see the benefit of a known lipid-lowering drug such as pitavastatin in patients with advanced prostate cancer who are being treated with the new anti-androgens. Se realiza un ensayo clínico para ver el beneficio que puede tener un fármaco hipolipemiante conocido como es pitavastatina en pacientes con cáncer de próstata avanzado y que están siendo tratados con los nuevos antiandrógenos |
|
|
| Not yet recruiting | 4 | 150 | Europe | Pitavastatin, Tablet, Pitavastatin: Livazo 2 mg | Fundación para la Investigación en Urología, Fundación para la Investigación en Urología (FIU) | We propose a multicenter, prospective, randomized, single-blind clinical trial, without conflict of interest, to determine the clinical benefit of statins (Pitavastatin 2 mg) in prostate cancer patients being treated with ARTA (enzalutamide, apalutamide, darolutamide and abiraterone). As primary objectives we will determine whether in the experimental group an increase in metastasis-free survival and radiological progression-free survival is achieved. Proponemos un ensayo clínico, randomizado y simple ciego, sin conflicto de intereses, para determinar el beneficio clínico de las estatinas en pacientes con cáncer de próstata que están siendo tratados con ARTA (enzalutamida, apalutamida, darolutamida y abiraterona). Como objetivos primarios determinaremos si en el grupo experimental se consigue un aumento de la supervivencia libre de metástasis y en la supervivencia libre de progresión radiológica., To determine whether a widely used drug (pitavastatin) may be beneficial in patients with advanced prostate cancer; it will be investigated whether it can delay disease progression. Determinar si un fármaco ampliamente utilizado (pitavastatina), puede ser beneficioso en pacientes con cancer de próstata avanzado; se investigará si puede retrasar la progresión de la enfermedad., Diseases [C] - Cancer [C04] | | | | |
CAPE-AMI, NCT04945122: Comparison of Atorvastatin and Pitavastatin on the Effect of HbA1c in AMI Patients With Abnormal Glucose Metabolism |
|
|
| Recruiting | 4 | 900 | RoW | Pitavastatin, Atorvastatin, Lipitor | Chinese Academy of Medical Sciences, Fuwai Hospital | Acute Myocardial Infarction, Glucose Metabolism Disorders | 12/22 | 12/23 | | |
ChiCTR2100051990: Efficacy and Safety of Rivaroxaban Versus Aspirin in Patients with Small Abdominal Aortic Aneurysm and Elevated High sensitivity C Protein: A Randomized Controlled Trail |
|
|
| Recruiting | 4 | 60 | | Rivaroxaban+pitavastatin ;Aspirin+pitavastatin | The PLA Northern Theater Command General Hospital; The PLA Northern Theater Command General Hospital, None | Abdominal aortic aneurysm | | | | |
NCT06273215: Evaluation of the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Diabetic Patients |
|
|
| Recruiting | 4 | 48 | RoW | The combinations of 10 µg midazolam, 375 µg dabigatran etexilate, 10 µg pitavastatin, 50 µg rosuvastatin, and 100 µg atorvastatin were administered to diabetic patients on an empty stomach. | Peking University Third Hospital | Diabetes | 12/25 | 12/25 | | |
PINTL, NCT05537948: Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients |
|
|
| Recruiting | 4 | 80 | RoW | Pitavastatin, PCSK9 inhibitor | National Medical Research Center for Therapy and Preventive Medicine | Dyslipidemias, Hyperlipidemias, Liver Transplant Disorder, Immunosuppression, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Statins | 06/24 | 01/25 | | |
PREVESTATGx, NCT06262685: Efficacy, Safety and Cost-efficacy of a Pre-emptive Genotyping Strategy in Patients Receiving Statins |
|
|
| Not yet recruiting | 4 | 216 | Europe | Preemptive pharmacogenetic atorvastatin dose based on CPIC guidelines, Preemptive pharmacogenetic simvastatin dose based on CPIC guidelines, Preemptive pharmacogenetic pitavastatin dose based on CPIC guidelines, Preemptive pharmacogenetic rosuvastatin dose based on CPIC guidelines, Preemptive pharmacogenetic pravastatin dose based on CPIC guidelines, Preemptive pharmacogenetic lovastatin dose based on CPIC guidelines, Preemptive pharmacogenetic fluvastatin dose based on CPIC guidelines, Standard of Care (SoC) dosing of atorvastatin, Standard of Care (SoC) dosing of simvastatin, Standard of Care (SoC) dosing of pitavastatin, Standard of Care (SoC) dosing of rosuvastatin, Standard of Care (SoC) dosing of prasavastatin, Standard of Care (SoC) dosing of lovastatin, Standard of Care (SoC) dosing of fluvastatin | Instituto de Investigación Hospital Universitario La Paz, Instituto de Salud Carlos III | Cardiovascular Diseases, Dyslipidemias, Statin Adverse Reaction, Pharmacogenic Myopathy | 02/25 | 03/25 | | |
NCT05747768: A Clinical Study to Evaluate the Pharmacokinetics of Microdose Midazolam, Dabigatran, Pitavastatin, Atorvastatin and Rosuvastatin in Healthy Volunteers and Renal Impairment Patients |
|
|
| Recruiting | 4 | 60 | RoW | Midazolam, dabigatran etexilate, pitavastatin, rosuvastatin and atorvastatin | Peking University Third Hospital | Chronic Kidney Disease | 06/24 | 12/24 | | |
